Caricamento...
Hämovigilanz von Blutkomponenten Meldungen an das Paul-Ehrlich-Institut vom 1.1.1995 bis zum 15.11.1998: Meldungen an das Paul-Ehrlich-Institut vom 1.1.1995 bis zum 15.11.1998
In Germany cellular blood products are a licensed medicinal product. In the following we would like to present the reporting procedure, analysis and evaluation of suspected cases from spontaneously recorded data. During the time period from 1.1.95 until 1.1. 98 a total of 1488 suspected adverse even...
Salvato in:
| Pubblicato in: | Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer-Verlag
1999
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7096064/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s001030050075 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|